Cargando…
Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial
BACKGROUND: Despite the reported success in reducing morbidity, praziquantel alone is insufficient for the control and elimination of schistosomiasis, partly due to its poor efficacy against the juvenile worms. Artemisinin derivatives are effective against juvenile worms but are less effective again...
Autores principales: | Mnkugwe, Rajabu Hussein, Minzi, Omary, Kinung’hi, Safari, Kamuhabwa, Appolinary, Aklillu, Eleni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510991/ https://www.ncbi.nlm.nih.gov/pubmed/32966290 http://dx.doi.org/10.1371/journal.pntd.0008619 |
Ejemplares similares
-
Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of Schistosoma mansoni Infection
por: Minzi, Omary Mashiku, et al.
Publicado: (2021) -
Effect of Pharmacogenetics Variations on Praziquantel Plasma Concentrations and Schistosomiasis Treatment Outcomes Among Infected School-Aged Children in Tanzania
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2021) -
Prevalence and correlates of intestinal schistosomiasis infection among school-aged children in North-Western Tanzania
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2020) -
Efficacy and Safety of Praziquantel for Treatment of Schistosoma mansoni Infection among School Children in Tanzania
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2019) -
Optimal single sampling time-point for monitoring of praziquantel exposure in children
por: Mnkugwe, Rajabu Hussein, et al.
Publicado: (2021)